Functional Characterization and Crystal Structure of the C215D Mutant of Protein-tyrosine Phosphatase-1B*

Yolanda Romsicki {ddagger} §, Giovanna Scapin ¶, Veronique Beaulieu-Audy {ddagger}, Sangita Patel ¶, Joseph W. Becker ¶, Brian P. Kennedy {ddagger} and Ernest Asante-Appiah {ddagger} ||

From the {ddagger}Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Pointe-Claire, Dorval, Quebec H9R 4P8, Canada and the Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, New Jersey 07065

Received for publication, April 11, 2003 , and in revised form, May 6, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
We have characterized the C215D active-site mutant of protein-tyrosine phosphatase-1B (PTP-1B) and solved the crystal structure of the catalytic domain of the apoenzyme to a resolution of 1.6 Å. The mutant enzyme displayed maximal catalytic activity at pH ~4.5, which is significantly lower than the pH optimum of 6 for wild-type PTP-1B. Although both forms of the enzyme exhibited identical Km values for hydrolysis of p-nitrophenyl phosphate at pH 4.5 and 6, the kcat values of C215D were ~70- and ~7000-fold lower than those of wild-type PTP-1B, respectively. Arrhenius plots revealed that the mutant and wild-type enzymes displayed activation energies of 61 ± 1 and 18 ± 2 kJ/mol, respectively, at their pH optima. Unlike wild-type PTP-1B, C215D-mediated p-nitrophenyl phosphate hydrolysis was inactivated by 1,2-epoxy-3-(p-nitrophenoxy)propane, suggesting a direct involvement of Asp215 in catalysis. Increasing solvent microviscosity with sucrose (up to 40% (w/v)) caused a significant decrease in kcat/Km of the wild-type enzyme, but did not alter the catalytic efficiency of the mutant protein. Structurally, the apoenzyme was identical to wild-type PTP-1B, aside from the flexible WPD loop region, which was in both "open" and "closed" conformations. At physiological pH, the C215D mutant of PTP-1B should be an effective substrate-trapping mutant that can be used to identify cellular substrates of PTP-1B. In addition, because of its insensitivity to oxidation, this mutant may be used for screening fermentation broth and other natural products to identify inhibitors of PTP-1B.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The protein-tyrosine phosphatases (PTPases)1 compose a family of ~100 enzymes that play an important role in controlling several biological processes, including cell cycles and signal transduction pathways (1, 2). One member of this family of phosphatases that is receiving increased attention because of its potential role in controlling the insulin signaling pathway is protein-tyrosine phosphatase-1B (PTP-1B). Studies have suggested that this ubiquitously expressed enzyme may play a role in regulating the function of the insulin receptor. Thus, PTP-1B is an attractive target for drug design in the treatment of Type II diabetes (for reviews, see Refs. 3 and 4).

Like other PTPases, PTP-1B contains a conserved 11-residue sequence motif (i.e. (I/V)HCXAGXXR(S/T)G) that harbors Cys215, which acts as the nucleophile and is essential for catalysis. The signature motif also forms the "P-loop" that is involved in substrate binding and catalysis. It is thought that PTP-1B-mediated catalysis occurs via a double-displacement mechanism in which the phosphoryl group of the substrate is first transferred to the active-site Cys residue (Cys215) (5, 6). The initial phosphoryl transfer is assisted by an invariant Asp residue (Asp181) residing in a flexible loop region (WPD loop) that spans the conserved tripeptide Trp-Pro-Asp. It is generally believed that Asp181 first acts as a general acid and protonates the leaving group in the phosphorylation step. Subsequently, Asp181 functions as a general base, abstracting a proton from an attacking water molecule in the dephosphorylation step to enhance the rate of hydrolysis of the enzyme-thiophosphate intermediate (710). Previous structural studies on PTP-1B have revealed interesting details regarding the conformations and structural organizations of the WPD loop and P-loop regions. Specifically, the WPD loop has been shown to adopt different conformations in the unliganded and liganded forms of the enzyme. In the unliganded structure, the WPD loop is in an open conformation, in which Asp181 is ~10 Å away from the P-loop. Upon substrate binding, the WPD loop adopts a closed conformation and covers the active site like a "flap," thereby positioning Asp181 closer to the leaving group (11, 12).

In wild-type PTP-1B, Cys215 is present as a thiolate (13), and it is known that this active-site residue is absolutely necessary for PTP-1B-mediated catalysis. Mutation of this residue to a neutral Ser generates a "substrate-trapping" mutant, which is able to bind substrates with affinities similar to those of the wild-type enzyme, but does not display any measurable phosphatase activity (14, 15). The crystal structure of the unliganded C215S PTP-1B mutant shows the P-loop in a conformationally distinct orientation compared with that found in the wild-type protein. However, in the liganded form, the P-loop adopts the same conformation as the wild-type protein. In the C215S mutant, substitution of the negatively charged thiolate with a neutral (although polar) alcohol destabilizes the PTPase signature motif loop (P-loop) and the surrounding areas, favoring the extended conformation (16). The structural studies therefore suggest that the conformation of the P-loop region of the enzyme is inducible and may be dependent on the presence of the negative charge of the active-site nucleophile. The goal of this study was to explore the importance of the presence of a negatively charged residue other than Cys at position 215 in the conformation of the P-loop and in the catalytic activity of PTP-1B. We therefore substituted Cys215 with Asp, as this residue is similar in charge and size density to the active-site thiolate. Here, we report the functional characterization and crystal structure of the C215D mutant enzyme and compare these properties with those of wild-type PTP-1B.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Materials—Bovine serum albumin and the SuperSignalTM West Pico immunoblotting kit were obtained from Pierce. SDS-polyacrylamide gels were purchased from Invitrogen, and Escherichia coli BL21 cells were obtained from Stratagene. Isopropyl-1-thio-{beta}-D-galactopyranoside and protease inhibitors were from Roche Applied Science. The Cibacron blue and Sepharose Q columns were bought from Amersham Biosciences. All other chemicals were obtained from Sigma.

General Methods—Protein concentrations were determined by a microplate adaptation of the Bradford assay using bovine serum albumin as a standard (47). For SDS-PAGE and immunoblotting of purified mutant and wild-type PTP-1B, proteins were boiled in SDS-PAGE loading buffer for 5–10 min and then separated on 10–20% (w/v) polyacrylamide gradient gels containing SDS. The proteins were transferred onto nitrocellulose at a constant voltage of 100 V for 90 min. The blot was subsequently probed with an anti-FLAG monoclonal antibody and detected by chemiluminescence. The SuperSignalTM West Pico kit was used for immunoblotting of proteins following the manufacturer's suggested protocol.

Mutagenesis and Protein Expression—A plasmid containing the isolated catalytic domain of human PTP-1B (residues 1–298) in a pFLAG vector was used as a template for site-directed mutagenesis. The Cys-to-Asp mutation was introduced using a PCR-based approach following established procedures (17). The resulting construct was verified by DNA sequencing on an ABI 373 DNA sequencer (Applied Biosystems), and the sequence data were analyzed using the software application package Sequencher Version 4.0.5 (Gene Code Corp.).

The resulting plasmid was transformed into E. coli BL21 cells for protein expression. The bacterial cultures were grown in LB broth at 37 °C with shaking at 250 rpm to an absorbance of 0.7. The cultures were then induced by the addition of 1 mM isopropyl-1-thio-{beta}-D-galactopyranoside and grown for an additional 2 h. Cells were harvested by centrifugation, and cell lysates were analyzed by electrophoresis and immunoblotting using the protocol outlined above.

Purification of Mutant and Wild-type PTP-1B—Purification of mutant and wild-type PTP-1B was performed as outlined previously (18). Briefly, E. coli BL21 cells transformed with the expression vector were suspended in lysis buffer consisting of 20 mM Tris-HCl, 0.1 mM EDTA, 5 mM dithiothreitol, and two tablets of CompleteTM protease inhibitors/50 ml of solution at a final pH of 7.5. Cell lysis was achieved by passing cells twice through an ice-chilled French pressure cell (SLM-AMINCO) at 16,000 p.s.i. The supernatant was retained following centrifugation of the cell lysate at 31,000 x g for 30 min and then applied to a Cibacron blue affinity column pre-equilibrated with lysis buffer without protease inhibitors (binding buffer A). Following application of the supernatant, the affinity column was washed with 20 column volumes of binding buffer A or until the absorbance at 280 nm returned to base-line levels. The protein was then eluted with a linear gradient of NaCl (0–500 mM) in binding buffer A over 10 column volumes. PTP-1B-rich fractions were determined by analyzing the fractions by SDS-PAGE and also by measuring PTPase activity. The appropriate fractions were pooled, and the ionic strength was adjusted to 100 mM NaCl. The partially purified preparation was subsequently applied to a Sepharose Q anion-exchange column pre-equilibrated with 20 mM Tris-HCl, 0.1 mM EDTA, 5 mM dithiothreitol, and 100 mM NaCl at pH 7.5 (binding buffer B). The column was then washed with binding buffer B to return the absorbance at 280 nm to base-line levels. Next, the protein was eluted with a linear gradient of increasing NaCl concentrations (100–500 mM) over 8 column volumes. The eluted fractions were analyzed by SDS-PAGE and by measuring enzyme activity; the appropriate fractions were then pooled. The purified protein preparation was dialyzed into 20 mM Tris-HCl, 0.1 mM EDTA, 5 mM dithiothreitol, 150 mM NaCl, and 20% (v/v) glycerol at pH 7.5 prior to storage at –80 °C. All steps in the purification scheme were carried out at 4 °C or on ice with the aid of a fast protein liquid chromatography apparatus (Amersham Biosciences); a flow rate of 1 ml/min was used in all chromatographic steps.

Activity Assays—Assays were carried out in a 96-well format at 22 °C in buffer consisting of 100 mM Tris-HCl, 50 mM MES, 50 mM acetic acid, N,N'-dimethylbis(mercaptoacetyl)hydrazine, 2 mM EDTA, 5% (v/v) Me2SO, 2% (v/v) glycerol, and 0.01% (v/v) Triton X-100 at the appropriate pH. The use of this triple-component buffering system minimizes changes in ionic strength across a pH range of 3–9 (19). Enzyme activity was quantitated by monitoring C215D or wild-type PTP-1B-catalyzed hydrolysis of p-nitrophenyl phosphate (pNPP) to p-nitrophenol. Briefly, pNPP hydrolysis was measured by incubating C215D or wild-type PTP-1B with 0–10 mM pNPP for 30 or 4 min, respectively, and then stopping the reaction by adding NaOH to a final concentration of 1 M. The absorbance at 405 nm was measured on a Cytofluor IITM plate reader, and the catalytic activity was calculated using the molar extinction coefficient of the p-nitrophenolate anion (18,800 M–1 cm1). The observed rates of reactions were fitted to the Michaelis-Menten equation using the nonlinear curve fitting software program Grafit Version 4.0.10 (Erithacus Software Inc.) to determine kinetic constants. To extract pKapp values from the pH-response studies, the data were also fitted using nonlinear regression analysis (SigmaPlot, Jandel Scientific).

For collection of Arrhenius plot data, C215D and wild-type PTP-1B activities were measured at their respective pH optima at 10–37 °C (±0.5 °C) using 10 mM pNPP as a substrate and an assay time of 30 or 4 min, respectively. The data were transformed into Arrhenius plots, and the slopes of the lines were obtained using linear regression with the Marquardt-Levenberg algorithm (SigmaPlot).

For inactivation assays using 1,2-epoxy-3-(p-nitrophenoxy)propane (EPNP), the epoxide was dissolved in Me2SO and added to the reaction mixtures to a final concentration of 2.4 mM. Following incubation of the enzymes for 1 h at 4 °C in the presence of EPNP, the catalytic activities were determined at their respective pH optima as described above.

Viscosity Studies—The effect of viscosity on C215D or wild-type PTP-1B activity was determined by measuring pNPP hydrolysis using the protocol outlined above in reaction mixtures containing 0–40% (w/v) sucrose. Stock solutions of sucrose were prepared at twice the desired final concentration in assay buffer (pH 4.5 or 6) and added to the reaction mixtures to obtain a 2-fold dilution. The plates were continuously shaken during the incubation time to maintain homogeneity of the reaction mixtures. Relative solvent viscosities ({eta}rel = {eta}/{eta}o, where the superscript o denotes the reaction in buffer lacking sucrose) were calculated using the solution densities at 22 °C (20, 21). The calculated relative viscosities used in these experiments were 1.00, 1.37, 2.02, 3.32, and 6.39 for 0, 10, 20, 30, and 40% (w/v) sucrose solutions, respectively.

Crystallization and Data Collection—Apo-C215D crystals were obtained by vapor diffusion in sitting drops at 4 °C by mixing 2 µl of protein (10 mg/ml in 20 mM HEPES, 50 NaCl, 1 mM EDTA, and 5 mM N,N'-dimethylbis(mercaptoacetyl)hydrazine, pH 7.0) and 2 µl of precipitant solution (13–16% polyethylene glycol 3350, 100 mM HEPES, and 200 mM MgCl2, pH 7.0). X-ray diffraction data were collected on an ADSC Q210 detector from a single crystal (~0.3 x 0.2 x 0.1 mm in size) using synchrotron radiation. Data to 1.6 Å were collected at beamline 17-ID in the facilities of the Industrial Macromolecular Crystallography Association Collaborative Access Team at the Advanced Photon Source. Data processing, scaling, and merging were done with the software DPS/MOSFLM (22, 23). The crystal was trigonal, with space group P312 and unit cell parameters a = b = 88.45 Å, c = 104.36 Å, {alpha} = {beta} = 90.0°, and {gamma} = 120°. See "Results" for the statistics for the data collected.

Structure Solution and Refinement—The crystal was isomorphous to previously reported PTP-1B crystals (i.e. Protein Data Bank 1PTY [PDB] ) (24), and the three-dimensional structure of the C215D mutant was solved by difference Fourier analysis using, as the initial model, the 1.8-Å structure of the mutant enzyme in complex with phosphotyrosine (Protein Data Bank code 1PTY [PDB] ). Bound ligand, solvent molecules, and protein residues 175–184 (WPD loop) and 213–223 (P-loop) were deleted from the coordinate file. The initial electron density maps to 2.4 Å calculated from this model showed that the WPD loop was in a closed conformation and that the peptide containing the catalytic site mutation assumed the same conformation observed in the wild-type enzyme (see Fig. 4). Both loops were built into the available density using the graphic software O (25). Refinement of the model was carried out by alternating cycles of manual rebuilding of the model in O and computer-based refinement using CNX, slowly including all available data to 1.6-Å resolution. Typically, two cycles of torsion angle dynamics and positional and temperature factor refinement were run in each cycle. Bulk solvent correction was applied throughout the entire refinement, and the refinement was performed using the cross-validated maximal likelihood approach (26, 27). When high resolution data were included, it became evident in the electron density maps that the WPD loop (Thr177–Ser188) was present in both "open" and "closed" conformations. Several other residues were also modeled as having dual conformation for their side chains; the occupancy for atoms in dual conformations was initially set to 50% for each conformer and then manually adjusted to reflect the temperature factors. At the end of the refinement, 30 additional cycles of occupancy refinement were carried out for the atoms modeled in the alternate configurations. See "Results" for the statistics for the refined model.



View larger version (30K):
[in this window]
[in a new window]
 
FIG. 4.
Crystal structure of the apo-C215D PTP-1B mutant. A is a schematic illustration of the bond network between various residues and the water molecules in the active site. B shows a stereo view of the PTP-1B catalytic center. Asp215 is identified with a van der Waals surface. The solvent molecules are represented as red spheres, and phosphotyrosine (from Protein Data Bank code 1PTY [PDB] ) is shown in green. For clarity, only hydrogen bonds involving solvent and protein atoms are shown. The alternate conformations observed for the WPD loop and the side chains of Arg221 and Ser216 are in cyan. This figure was made with RIBBONS (46).

 


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
To evaluate the importance of a negatively charged residue at position 215 of PTP-1B, we substituted Cys215 with Asp. The isosteric nature of this amino acid replacement minimizes the introduction of structural perturbations in the conformation of the P-loop. Following expression and purification of the C215D mutant, the functional and structural properties of the enzyme were compared with those of wild-type PTP-1B.

Effect of pH on C215D Activity—We investigated the pH dependence of C215D and wild-type PTP-1B-catalyzed hydrolysis of pNPP at pH 3.5–9 (Fig. 1). Although the pH profiles were generally bell-shaped for both enzymes, suggesting the existence of two ionizable amino acid side chains involved in catalysis, significant differences in the profiles were noted. As expected, wild-type PTP-1B displayed maximal catalytic activity at pH 6.0; however, when the active-site Cys was replaced with Asp, the pH optimum of the enzyme was shifted to 4.5–4.7. Interestingly, the pH profiles showed very little overlap, and significant differences in the relative levels of catalytic activity were observed at the pH optima of the two enzymes. For example, at pH 4.5, where the C215D mutant displayed maximal activity, the catalytic activity of wild-type PTP-1B was <5% of its maximum. Similarly, whereas wild-type PTP-1B exhibited maximal catalytic activity at pH 6, only 15% of the maximal catalytic activity of the C215D mutant was present. From the pH profiles, the first and second apparent ionization constants of the enzyme-substrate complexes (i.e. pK1(app) and pK2(app)) for wild-type PTP-1B were estimated to be ~5.5 and 6.8, respectively. Due to the steep slope of the acid limb of the pH profile for the C215D mutant, the pK1(app) could not be determined accurately, and it could only be estimated that the value was between 4.3 and 4.5. According to the pH profile, the pK2(app) of the mutant enzyme (~5.5) was also significantly lower than that of wild-type PTP-1B. These results clearly show that the two forms of the enzyme displayed distinct pH dependences with respect to substrate hydrolysis.



View larger version (15K):
[in this window]
[in a new window]
 
FIG. 1.
Effect of pH on the catalytic activities of C215D and wild-type PTP-1B. The catalytic activities of wild-type ({circ}) and C215D (•) PTP-1B were determined using 10 mM pNPP as a substrate in assay buffers adjusted to the appropriate pH values. The data are presented as percent activity observed at the optimal pH for each protein. Data points represent the means of triplicate determinations; where error bars are not visible, they fall within the symbols.

 

Comparison of Km, kcat, and Eact of Mutant and Wild-type PTP-1B—Next, we compared the kinetic parameters of the C215D mutant with those of wild-type PTP-1B. Table I shows a comparison of the kinetic parameters of C215D and wild-type PTP-1B-mediated pNPP hydrolysis at the determined pH optima. Although both enzymes displayed similar Km values of 1.1–1.4 mM, the kcat values of the C215D mutant were ~70- and ~7000-fold lower than those of wild-type PTP-1B at pH 4.5 and 6, respectively.


View this table:
[in this window]
[in a new window]
 
TABLE I
Kinetic parameters of C215D and wild-type PTP-1B-mediated pNPP hydrolysis at pH 4.5 and 6

The data represent the means ± S.E. of three independent determinations.

 

To determine whether the observed differences in kcat between the mutant and wild-type enzymes could be at least partially explained by potential differences in the thermodynamics of catalysis, we compared the activation energies (Eact) of C215D and wild-type PTP-1B-catalyzed pNPP hydrolysis by measuring the catalytic activities as a function of temperature. The Arrhenius plots and the corresponding calculated Eact values for C215D and wild-type PTP-1B are shown in Fig. 2 and Table II, respectively. The Arrhenius plot for wild-type PTP-1B-mediated catalysis was continuous over the temperature range of 10–35 °C, with Eact = 18 ± 2 kJ/mol. At temperatures above 35 °C, significant denaturation of the enzyme was observed (data not shown). The C215D mutant was more thermally labile, and a continuous Arrhenius plot was obtained only up to 32 °C. Above this temperature, the Arrhenius plot also began to level off due to thermal denaturation of the enzyme. Interestingly, the Eact for the C215D mutant (i.e. 61 ± 1 kJ/mol) was >3-fold higher than that for wild-type PTP-1B.



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 2.
Arrhenius plots of the initial rates of C215D (A) and wild-type (B) PTP-1B-mediated pNPP hydrolysis at various temperatures. Rates were determined by measuring the absorbance of the reaction mixtures at 405 nm. Data points represent the means of triplicate determinations; where not visible, error bars are masked by the symbols. The solid lines indicate the calculated best fit lines using linear regression analysis.

 

View this table:
[in this window]
[in a new window]
 
TABLE II
Activation energies for pNPP hydrolysis by C215D and wild-type PTP-1B

Eact values were calculated from the slopes of the lines in Fig. 2.

 

Inactivation of C215D-mediated Catalysis by EPNP—EPNP is a potent inactivator of enzymes that possess an active-site carboxyl residue (for example, see Refs. 2830). Irreversible inactivation is presumably due to alkylation of the active-site carboxyl residue by the epoxide moiety of EPNP. Because the C215D mutant contains a carboxyl residue in its active site, we wished to determine the effect of EPNP on the catalytic activity of this mutant derivative of PTP-1B. We therefore monitored the amount of C215D and wild-type PTP-1B catalytic activities that remained following a 1-h incubation of the enzymes at 4 °C in the presence of 2.4 mM EPNP. The activity of the mutant protein was reduced by >80% following incubation of the enzyme in the presence of the inactivator (Fig. 3). However, the activity of wild-type PTP-1B was not significantly affected under similar conditions. As the only amino acid difference between the mutant and wild-type enzymes was the substitution of the catalytic Cys215 with Asp in the derivative, we conclude that EPNP inactivated C215D through alkylation of the carboxyl group of Asp215.



View larger version (12K):
[in this window]
[in a new window]
 
FIG. 3.
Effect of EPNP on C215D and wild-type PTP-1B-catalyzed pNPP hydrolysis. The catalytic activities of C215D and wild-type (WT) PTP-1B were measured following a 1-h incubation at 4 °C in the absence (black bars) or presence (gray bars) of 2.4 mM EPNP using 10 mM pNPP as a substrate. The data represent the means of triplicate determinations, and activity is expressed as percent maximal activity of C215D and wild-type PTP-1B at pH 4.5 and 6, respectively.

 

Crystal Structure of the Apo-C215D Mutant—To evaluate the effect of the Cys-to-Asp substitution on the tertiary structure of PTP-1B, we solved the x-ray crystal structure of the mutant enzyme and refined it against 1.6-Å data. The final model had a crystallographic R-factor of 18.6% (Rfree is 20.4%) for 59,409 reflections between 15.0 and 1.6 Å (5% flagged for Rfree calculation) and maintained good geometry (root mean square deviations for bond lengths and bond angles of 0.01 Å and 1.5°, respectively (Table III)). The backbone conformation of 91.6% of the residues was within the most favored regions of the Ramachandran plot, with none in disallowed regions, as defined using PROCHECK (31). The side chains of Met3, Asp48, Pro87, Arg105, Ser118, Leu119, Gln157, Glu159, Ser190, Ser216, Arg221, Cys226, Ile246, Met253, and Ser285 were modeled as having dual conformations. Two peptides (His60–Asp63 and Thr177–Ser188, the WPD loop) and five solvent molecules were also modeled as having alternate conformations. The P-loop is in the wild-type conformation (Fig. 4), and extensive hydrogen bond interactions are present between the Asp215 carboxylate and the main chain and side chain nitrogens of Ser216, Ala217, Gly218, and Ser222, and the side chain oxygen of Ser222 as depicted schematically in Fig. 4A. Asp215 is also hydrogen-bonded to one of several ordered water molecules located in the binding site. This water is located at the position normally occupied by one of the phosphate oxygens of Tyr(P) in the Protein Data Bank 1PTY [PDB] structure (Fig. 4B) and makes similar hydrogen bond interactions with the main chain nitrogens of Ile219 and Gly220. A second water molecule occupies the position of another phosphate oxygen, but appears to be quite mobile; and it has been modeled as having two distinct positions. This water molecule interacts with the main chain and {epsilon}-nitrogen of Arg222, the side chain oxygen of Asp215, and three water molecules. The other four solvent molecules, at least one of which appears to be quite delocalized, have been located in the binding site; together, these molecules form an extensive hydrogen bond network connecting Asp215 to Asp181 in the WPD loop (Fig. 4, A and B). The WPD loop assumes both conformations: the catalytically active closed conformation (preferred, with an average occupancy of 73.1% and an average temperature factor of 17.6 Å2) and the inactive open conformation typical of the unliganded enzyme. This alternate position refined to a much lower occupancy (26.9% on average, with an average temperature factor of 22.8 Å2), but electron density was clearly available in the difference Fourier maps that could be justified only by assuming a partially open loop. Following the two different positions of the WPD loop, the side chain of Arg221 also assumes two distinct conformations (with similar occupancies) that indeed correspond to the conformations previously observed in the apo- and liganded PTP-1B (Protein Data Bank codes 2HNP [PDB] and 1PTY [PDB] , respectively).


View this table:
[in this window]
[in a new window]
 
TABLE III
Statistics for the data set used to solve the structure of the apo-C215D mutant of PTP-1B and final statistics for the refined model

Numbers in parentheses refer to the last resolution shell. r.m.s.d., root mean square deviation.

 

Effect of Viscosity on C215D and Wild-type PTP-1B-mediated Substrate Hydrolysis—As the major structural difference between the wild-type enzyme and the C215D derivative was observed in the conformation of the WPD loop, we wished to investigate this further. Therefore, we evaluated the contribution of loop motion to C215D and wild-type PTP-1B-mediated catalysis by monitoring the effect of solvent microviscosity. We measured the Km and kcat of enzyme-catalyzed hydrolysis of pNPP in the presence of increasing concentrations of sucrose. As shown in Fig. 5A, the kcat of the wild-type enzyme was slightly higher in the presence of 40% (w/v) sucrose. However, there was a 30% decrease in kcat/Km of wild-type PTP-1B (Fig. 5B), suggesting that the catalytic efficiency of wild-type PTP-1B was significantly hindered in the presence of sucrose. In contrast, there was no change in either the Km or kcat of C215D-mediated catalysis under similar conditions, resulting in a lack of deviation of (kcat/Km)o/(kcat/Km){eta} as a function of relative solvent microviscosity (Fig. 5, C and D).



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 5.
Dependence of relative kinetic parameters for C215D and wild-type PTP-1B-catalyzed pNPP hydrolysis on solvent viscosity. A and C show the dependence of kcat on solvent viscosity for wild-type and C215D PTP-1B, respectively. B and D show the effect of solvent viscosity on kcat/Km for wild-type and C215D PTP-1B, respectively. The parameters were determined by measuring the catalytic activities of the enzymes in the presence of increasing concentrations of sucrose. Data points represent the means of duplicate experiments. The solid lines indicate the calculated best fit lines using linear regression analysis.

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Previously, we reported that substitution of Cys215 with Ser results in a conformationally distinct P-loop in the unliganded mutant enzyme, and we suggested that a negative charge in the active site is required to maintain the P-loop conformation observed in the wild-type enzyme (16). In this study, we generated and characterized the C215D mutant of PTP-1B to obtain further insights into the structural basis of PTP-1B catalysis. We substituted Cys215 with Asp to preserve both the charge and size of this active-site residue.

Substitution of the active-site Cys with Asp resulted in a dramatic change in the pH profile for PTP-1B-catalyzed hydrolysis of pNPP. As expected, wild-type PTP-1B displayed a pH optimum of ~6. This value agrees favorably with the optimum values of 5.5–6.5 determined previously for the enzyme (32, 33). In contrast, the pH optimum for the C215D mutant was shifted to a significantly lower value of 4.5–4.7 and likely reflects the fact that the active-site Cys, which displays a pKa of ~5.5 in wild-type PTP-1B (13), was replaced with the strongly acidic Asp residue, with a pKa of ~4 in model systems. The lower pH optimum of the C215D derivative is similar to the pH optima of some enzymes that contain active-site Asp residues such as pepsin (28) and the simian immunodeficiency virus protease (34).

Interestingly, both forms of PTP-1B displayed identical Km values at the pH optimum of the C215D mutant. The Km values of 5.4 and 5.8 mM for pNPP for both mutant and wild-type PTP-1B, respectively, were 4-fold higher than the Km values determined at pH 6. That both PTPases displayed the same shift in Km at a lower pH suggests that the increase in Km was not a result of substitution of the active-site Cys with Asp. Rather, the increase in Km may be due to the influence of pH on the ionization state of the substrate or may be a result of alterations in the ionization states of other important residues in the vicinity of the active-site regions of the proteins. At pH 4.5, C215D-mediated pNPP hydrolysis still remained >70-fold lower than wild-type enzyme-mediated pNPP hydrolysis at the same pH. Thus, substitution of the strongly nucleophilic active-site Cys with negatively charged Asp caused a significant reduction in the rate of substrate turnover that could not be reversed to that of the wild-type enzyme at the pH optimum of the mutant protein.

The Arrhenius plots for C215D and wild-type PTP-1B revealed that the activation energy of C215D-mediated pNPP hydrolysis was >3-fold higher than that of the reaction catalyzed by wild-type PTP-1B. The plots were linear over temperature ranges of 10–32 °C for the C215D mutant and 10–35 °C for the wild-type enzyme and did not reveal any discontinuities over the temperature ranges. Thus, the large drop in kcat observed for the mutant protein with respect to pNPP hydrolysis may be partially attributable to the 3-fold higher activation energy of C215D-mediated catalysis. The crystal structure of the apo-C215D mutant shows several water molecules sequestered at the active site. These water molecules would have to be excluded from the active site to enable substrate binding and catalysis. Thus, we hypothesize that the energy penalty that would result from the desolvation of the active site would translate to the higher activation energy observed for the mutant protein.

EPNP is a potent inactivator of enzymes that possess an active-site carboxyl residue and has been used to study the kinetic mechanisms of various aspartyl proteases such as pepsin (28) and the simian and human immunodeficiency virus proteases (for example, see Refs. 30 and 35). Inactivation by this uncharged molecule is presumably due to alkylation of the active-site carboxyl residue by the epoxide moiety of EPNP. Inactivation of the C215D derivative by EPNP and the lack of an effect on wild-type PTP-1B suggest a direct involvement of Asp215 in the catalytic mechanism of the mutant protein. Previously, Zhang et al. (36) showed that EPNP also acts as an irreversible inactivator of the low molecular weight PTPase from bovine heart. In the case of this PTPase, however, two cysteine residues were proposed to be the target of the epoxide. As EPNP did not significantly inhibit or inactivate wild-type PTP-1B, it seems reasonable to suggest that the irreversible inactivation of the C215D mutant was a result of a chemical modification of the active-site Asp by the epoxide as observed for aspartyl proteases. These results corroborate the pH studies and provide strong evidence that Asp215 is crucial to the reaction mechanism of the mutant protein.

Structurally, wild-type PTP-1B and the C215D derivative are identical, with the exception of the so-called WPD loop, which appears in both open and closed conformations in the mutant protein. The closed conformation is clearly favored over the open conformation (relative occupancies of 73.1 and 26.9%, respectively) and is probably induced by the extensive hydrogen bond network, involving both solvent and protein atoms, identified in the binding site (Fig. 4). These differences in the flexible WPD loop prompted us to investigate whether solvent microviscosity could affect the catalytic properties of these two enzymes. If rapid movement of the WPD loop is crucial to the catalytic mechanism of PTP-1B, then it is possible that increasing solvent microviscosity could have a detrimental effect on PTP-1B-mediated catalysis by imposing a physical energy barrier to the movement of this region. The catalytic domain (residues 1–298) of wild-type PTP-1B was influenced by solvent microviscosity, resulting in a 30% decrease in kcat/Km in the presence of 40% (w/v) sucrose, primarily stemming from a higher Km value. In addition, we have performed similar viscosity studies on the highly homologous T-cell PTPase and have found that the catalytic efficiency of the corresponding region of this enzyme (i.e. amino acids 1–296) responded to changes in solvent microviscosity in a manner similar to PTP-1B (data not shown). Specifically, kcat/Km of T-cell PTPase-catalyzed pNPP hydrolysis was ~1.5-fold lower in the presence of 40% (w/v) sucrose. The decrease in catalytic efficiency in the presence of sucrose is consistent with the hypothesis that movement of the WPD loop is crucial to the catalytic mechanism of PTP-1B. However, increasing the relative viscosity to the same extent did not influence either the Km or kcat of the C215D mutant and hence resulted in no change in the second-order rate constant of C215D-mediated pNPP hydrolysis. A comparison of the crystal structures of apo-C215D and wild-type PTP-1B gives an insight into the effect of increasing solvent viscosity on catalytic efficiency. The closed conformation necessary for catalysis is observed in the apo-C215D structure, but not in the wild-type apo-PTP-1B structure. This suggests that there is a higher propensity for the loop to assume the catalytically competent conformation in the mutant derivative even in absence of substrate than in the wild-type enzyme. It seems possible that this structural change in the WPD loop conformation in the C215D mutant, which results in a preformed active site, influences the lack of sensitivity to the increasing solvent microviscosity. This induced fit mechanism may explain the higher Km value for the wild-type enzyme in the presence of the viscogen.

An important strategy in the identification of potential substrates of PTPases is the use of substrate-trapping mutants that are structurally similar to the wild-type enzyme, but display either a lower dissociation constant between the enzyme and the substrate or a slower substrate turnover. To date, four examples of substrate-trapping mutants have been used to characterize PTP-1B. In the first case, the active-site Cys is replaced with Ser (3739). This mutant still retains the ability to bind substrates, but displays no measurable catalytic activity. However, differences in the thermodynamic parameters for ligand binding between the human form of the C215S mutant and wild-type PTP-1B have been noted (40) and could be partially explained by the observed altered conformation of the P-loop in the mutant enzyme (16). In the second type of substrate-trapping mutant, the general acid Asp (i.e. Asp181) is replaced with Ala (41, 42). Like the C215S mutant, this enzyme also binds substrate, but its catalytic activity is drastically reduced (42, 43). A third type of substrate-trapping mutant is the Q262A derivative, which has been used to obtain a crystal structure of the phosphoryl-enzyme intermediate (44). Recently, a double mutant (D181A/Q262A) of PTP-1B has been generated. This substrate-trapping mutant exhibits higher affinity than both the independent D181A and C215S mutants for the epidermal growth factor receptor and displays 3000- and 11,000-fold lower kcat values for pNPP and epidermal growth factor receptor, respectively (45). It is currently unknown, however, how this mutant compares structurally with wild-type PTP-1B.

In wild-type PTP-1B, Cys215 functions as a strong nucleophile, forming a cysteinyl-phosphate intermediate in the reaction mechanism. We hypothesized that substitution of this residue with negatively charged Asp would decrease the catalytic activity of the enzyme. We observed that the turnover number of the C215D mutant was indeed significantly lower (>7000-fold) than that of the wild-type protein at pH 6, suggesting that this PTP-1B derivative may also serve as a highly efficient substrate-trapping derivative of the enzyme.

In this study, we have characterized some of the functional properties of the C215D derivative of PTP-1B. Although the results of this study suggest that Asp215 is involved in catalysis, it is currently unknown whether the catalytic mechanism of this derivative is identical to that of the wild-type enzyme or is somewhat altered. Experiments are underway in our laboratory to address this question. Nonetheless, the C215D enzyme is a novel substrate-trapping mutant whose structure is nearly identical to, but displays significantly lower catalytic activity than, wild-type PTP-1B. Thus, C215D could be used to isolate and identify physiological substrates of PTP-1B. Introduction of a carboxylate residue in place of a thiolate has rendered the enzyme resistant to oxidation; and therefore, this mutant may also be used for screening of fermentation broth and natural products to identify inhibitors of PTP-1B. Preliminary studies in our laboratory indicate that the profiles of inhibitors screened with the mutant enzyme are equivalent to those obtained with the wild-type enzyme.


    FOOTNOTES
 
The atomic coordinates and structure factors (code 1PA1) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* The work carried out in the facilities of the Industrial Macromolecular Crystallography Association Collaborative Access Team was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Illinois Institute of Technology, executed through the Illinois Institute of Technology Center for Synchrotron Radiation Research and Instrumentation. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

§ Recipient of a Natural Sciences and Engineering Research Council of Canada post-doctoral industrial research fellowship. Back

|| To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, P. O. Box 1005, Pointe-Claire, Dorval, Quebec H9R 4P8, Canada. Tel.: 514-428-3452; Fax: 514-428-8615; E-mail: Ernest_Asanteappiah{at}Merck.com.

1 The abbreviations used are: PTPases, protein-tyrosine phosphatases; PTP-1B, protein-tyrosine phosphatase-1B; MES, 4-morpholineethanesulfonic acid; pNPP, p-nitrophenyl phosphate; EPNP, 1,2-epoxy-3-(p-nitrophenoxy)propane. Back


    ACKNOWLEDGMENTS
 
We thank the staff at the facilities of the Industrial Macromolecular Crystallography Association Collaborative Access Team for help during data collection.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. van Huijsduijnen, R. H. (1998) Gene (Amst.) 225, 1–8[CrossRef][Medline] [Order article via Infotrieve]
  2. Zhang, Z.-Y. (1998) Crit. Rev. Biochem. Mol. Biol. 33, 1–52[Abstract]
  3. Kennedy, B. P., and Ramachandran, C. (2000) Biochem. Pharmacol. 60, 877–883[CrossRef][Medline] [Order article via Infotrieve]
  4. Ukkola, O., and Santaniemi, M. (2002) J. Intern. Med. 251, 467–475[CrossRef][Medline] [Order article via Infotrieve]
  5. Guan, K. L., and Dixon, J. E. (1991) J. Biol. Chem. 266, 17026–17030[Abstract/Free Full Text]
  6. Cho, H., Krishnaraj, R., Bannwarth, W., Walsh, C. T., and Anderson, K. S. (1992) J. Am. Chem. Soc. 114, 7296–7298
  7. Zhang, Z.-Y., Wang, Y., Wu, L., Fauman, E., Stuckey, J. A., Schubert, H. L., Saper, M. A., and Dixon, J. E. (1994) Biochemistry 33, 15266–15270[Medline] [Order article via Infotrieve]
  8. Hengge, A. C., Sowa, G., Wu, L., and Zhang, Z.-Y. (1995) Biochemistry 34, 13982–13987[Medline] [Order article via Infotrieve]
  9. Wu, L., and Zhang, Z.-Y. (1996) Biochemistry 35, 5426–5434[CrossRef][Medline] [Order article via Infotrieve]
  10. Denu, J. M., Lohse, D. L., Vijayalakshmi, J., Saper, M. A., and Dixon, J. E. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 2493–2498[Abstract/Free Full Text]
  11. Barford, D., Flint, A. J., and Tonks, N. K. (1994) Science 263, 1397–1404[Medline] [Order article via Infotrieve]
  12. Jia, Z., Barford, D., Flint, A. J., and Tonks, N. K. (1995) Science 268, 1754–1758[Medline] [Order article via Infotrieve]
  13. Dillet, V., Van Etten, R. L., and Bashford, D. (2000) J. Phys. Chem. 104, 11321–11333
  14. Zhang, Z.-Y., and Wu, L. (1997) Biochemistry 36, 1362–1369[CrossRef][Medline] [Order article via Infotrieve]
  15. Skorey, K. I., Kennedy, B. P., Friesen, R. W., and Ramachandran, C. (2001) Anal. Biochem. 291, 269–278[CrossRef][Medline] [Order article via Infotrieve]
  16. Scapin, G., Patel, S., Patel, V., Kennedy, B., and Asante-Appiah, E. (2001) Protein Sci. 10, 1596–1605[Abstract/Free Full Text]
  17. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., and Struhl, K. (1992) Short Protocols in Molecular Biology, Green Publishing Associates/John Wiley & Sons, Inc., New York
  18. Asante-Appiah, E., Ball, K., Bateman, K., Skorey, K., Friesen, R., Desponts, C., Payette, P., Bayly, C., Zamboni, R., Scapin, G., Ramachandran, C., and Kennedy, B. P. (2001) J. Biol. Chem. 276, 26036–26043[Abstract/Free Full Text]
  19. Ellis, K. J., and Morrison, J. F. (1982) Methods Enzymol. 87, 405–426[Medline] [Order article via Infotrieve]
  20. Bubnik, Z., Kadlek, D., Urban, D., and Bruhns, M. (1995) Sugar Technologists Manual, Verlag Dr. Albert Bartens KG, Berlin
  21. Mathlouthi, M., and Genotelle, J. (1995) Sucrose: Properties and Applications, Blackie Academic and Professional, Glasgow, United Kingdom
  22. Rossmann, M. G., and van Beek, C. G. (1999) Acta Crystallogr. Sect. D Biol. Crystallogr. 55, 1631–1653[CrossRef][Medline] [Order article via Infotrieve]
  23. Leslie, A. G. W. (1990) Crystallographic Computing, Oxford University Press, Oxford
  24. Puius, Y. A., Zhao, Y., Sullivan, M., Lawrence, D. S., Almo, S. C., and Zhang, Z.-Y. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 13420–13425[Abstract/Free Full Text]
  25. Jones, A. T., and Kjeldgaard, M. (1997) Methods Enzymol. 277, 173–208[CrossRef]
  26. Pannu, N. S., and Read, R. J. (1996) Acta Cryst. Sect. A 52, 659–668[CrossRef]
  27. Adams, P. D., Pannu, N. S., Read, R. J., and Brünger, A. T. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 5018–5023[Abstract/Free Full Text]
  28. Tang, J. (1971) J. Biol. Chem. 246, 4510–4517[Abstract/Free Full Text]
  29. Rose, R. B., Rose, J. R., Salto, R., Craik, C. S., and Stroud, R. M. (1993) Biochemistry 32, 12498–12507[Medline] [Order article via Infotrieve]
  30. Salto, R., Babe, L. M., Li, J., Rose, J. R., Yu, Z., Burlingame, A., De Voss, J. J., Sui, Z., Ortiz de Montellano, P., and Craik, C. S. (1994) J. Biol. Chem. 269, 10691–10698[Abstract/Free Full Text]
  31. Laskoswski, R. A., MacArthur, M. W., Moss, S. D., and Thornton, J. M. (1993) J. Appl. Crystallogr. 26, 283–291[CrossRef]
  32. Tonks, N. K., Diltz, C. D., and Fischer, E. H. (1988) J. Biol. Chem. 263, 6731–6737[Abstract/Free Full Text]
  33. Hoppe, E., Berne, P.-F., Stock, D., Rasmussen, J. S., Moller, N. P. H., Ullrich, A., and Huber, R. (1994) Eur. J. Biochem. 223, 1069–1077[Abstract]
  34. Sugrue, R. J., Almond, N., Kitchin, R., Richardson, S. M., and Wilderspin, A. F. (1994) Protein Expression Purif. 5, 76–83[CrossRef][Medline] [Order article via Infotrieve]
  35. Yu, Z., Caldera, P., McPhee, F., De Voss, J. J., Jones, P. R., Bulingame, A., Kuntz, I. D., Craik, C. S., and Ortiz de Montellano, P. R. (1996) J. Am. Chem. Soc. 118, 5846–5856[CrossRef]
  36. Zhang, Z.-Y., Davis, J. P., and Van Etten, R. L. (1992) Biochemistry 31, 1701–1711[Medline] [Order article via Infotrieve]
  37. Bliska, J. B., Clemens, J. C., Dixon, J. E., and Falkow, S. (1992) J. Exp. Med. 176, 1625–1630[Abstract]
  38. Sun, H., Charles, C. H., Lau, L. F., and Tonks, N. K. (1993) Cell 75, 487–493[Medline] [Order article via Infotrieve]
  39. Milarski, K. L., Zhu, G., Pearl, C. G., McNamara, D. J., Dobrusin, E. M., Maclean, D., Thieme-Sefler, A., Zhang, Z.-Y., Sawyer, T., Decker, S. J., Dixon, J. E., and Saltiel, A. R. (1993) J. Biol. Chem. 268, 23634–23639[Abstract/Free Full Text]
  40. Zhang, Y.-L., Yao, Z.-J., Sarmiento, M., Wu, L., Burke, T. R. Jr., and Zhang, Z.-Y. (2000) J. Biol. Chem. 275, 34205–34212[Abstract/Free Full Text]
  41. Garton, A. J., Flint, A. J., and Tonks, N. K. (1996) Mol. Cell. Biol. 16, 6408–6418[Abstract]
  42. Flint, A. J., Tiganis, T., Barford, D., and Tonks, N. K. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1680–1685[Abstract/Free Full Text]
  43. Zhang, Z.-Y., Wang, Y., and Dixon, J. E. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 1624–1627[Abstract]
  44. Pannifer, A. D. B., Flint, A. J., Tonks, N. K., and Barford, D. (1998) J. Biol. Chem. 273, 10454–10462[Abstract/Free Full Text]
  45. Xie, L., Zhang, Y.-L., and Zhang, Z.-Y. (2002) Biochemistry 41, 4032–4039[CrossRef][Medline] [Order article via Infotrieve]
  46. Carson, M. (1997) Methods Enzymol. 277, 493–505
  47. Bradford, M. M. (1976) Anal. Chem. 72, 248–254




This Article
Abstract
Full Text (PDF)
All Versions of this Article:
278/31/29009    most recent
M303817200v1
Purchase Article
View Shopping Cart
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Copyright Permissions
Google Scholar
Articles by Romsicki, Y.
Articles by Asante-Appiah, E.
Articles citing this Article
PubMed
PubMed Citation
Articles by Romsicki, Y.
Articles by Asante-Appiah, E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   Biochemistry and Molecular Biology Education 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.